Clinical observations on the use of new anti-VEGF drug conbercept in age-related macular degeneration therapy: a meta-analysis

摘要

PurposeConbercept is a new anti-vascular endothelial growth factor (VEGF) drug approved for the treatment of age-related macular degeneration (AMD). Although this novel drug has been widely used in clinic, unlike other anti-VEGF drugs, validation and consensus on its method of clinical application and clinical safety have not yet been achieved.